An Efficient and Scalable Synthesis of (2R,αS)-3,4-Dihydro-2-[3-(1, 1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-α-(trifluoromethyl)-1(2H)-quinolineethanol: A Potent CETP Inhibitor

被引:0
作者
Wang, Aihua [1 ]
Zhang, Yan [1 ]
Lu, Songfeng [1 ]
Murray, William V. [1 ]
Kuo, Gee-Hong [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Drug Discovery, Spring House, PA 19477 USA
关键词
LIPID TRANSFER PROTEINS; CORONARY-HEART-DISEASE; LIPOPROTEIN CHOLESTEROL; DISCOVERY; REDUCTION; DESIGN;
D O I
10.1002/jhet.488
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
An efficient and scalable synthesis of the potent CETP inhibitor, (2R,alpha S)-3,4-dihydro-2[3-(,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)phenyl]-alpha-(trifluoromethyl)-1(2H)-quinolineethanol 1, is described. One of the important intermediates, tetrahydroquinoline 10, was readily prepared by reductive cyclization of nitroketone 9 in high yield. Asymmetric synthesis of 10 with high enantiomeric excess (>80% ee) was also developed.
引用
收藏
页码:1406 / 1410
页数:5
相关论文
共 25 条
[1]   High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A ;
Huang, YD .
ATHEROSCLEROSIS, 1996, 124 :S11-S20
[2]   Atheroprotective effects of high-density lipoproteins [J].
Assmann, G ;
Nofer, JR .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :321-341
[3]   ASYMMETRIC REDUCTION OF 7,8-DIFLUORO-3-METHYL-2H-1,4-BENZOXAZINE - SYNTHESIS OF A KEY INTERMEDIATE OF (S)-(-)-OFLOXACIN (DR-3355) [J].
ATARASHI, S ;
TSURUMI, H ;
FUJIWARA, T ;
HAYAKAWA, I .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1991, 28 (02) :329-331
[4]   Synthesis and antibacterial activity of some 5-(4-biphenylyl)-7-aryl[3,4-d] [1,2,3]-benzothiadiazoles [J].
Balasankar, T ;
Gopalakrishnan, M ;
Nagarajan, S .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (07) :728-731
[5]   SELECTIVE REDUCTION OF AROMATIC NITRO-COMPOUNDS WITH STANNOUS CHLORIDE IN NON-ACIDIC AND NON-AQUEOUS MEDIUM [J].
BELLAMY, FD ;
OU, K .
TETRAHEDRON LETTERS, 1984, 25 (08) :839-842
[6]   Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport [J].
Bruce, C ;
Chouinard, RA ;
Tall, AR .
ANNUAL REVIEW OF NUTRITION, 1998, 18 :297-330
[7]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[8]  
Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P1987, DOI 10.1002/(SICI)1521-3773(19980817)37:15<1986::AID-ANIE1986>3.0.CO
[9]  
2-Z
[10]   RANGE OF SERUM-CHOLESTEROL VALUES IN THE POPULATION DEVELOPING CORONARY-ARTERY DISEASE [J].
KANNEL, WB .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (09) :C69-C77